Panacea Biotec Ltd.

₹410.35

Panacea Biotec Ltd.

  • NSE : PANACEABIO

₹410.35

₹410.35

-7.8 (-1.87%) - 5 Jul 2025 10:01 AM
  • NSE : PANACEABIO

About Company

Panacea Biotec Limited is one of India’s leading research-based biotechnology companies engaged in the business of research, development, manufacture and marketing of vaccines in India and international markets. The company is well acknowledged by the United Nations (UN) Health Agencies in partnering the Global Polio Eradication Initiative (GPEI) with supplies of billions of doses of WHO Pre-qualified Polio vaccines in more than 50 countries worldwide as a sequel to the completion of full range of Oral polio vaccines (tOPV, mOPV1, mOPV3 & bOPV (Type1&Type3).

Market Cap. ₹ 2,513 Cr.
52 Week - High/Low ₹ 491/112
P/E Ratio
P/B Ratio 7.64
Enterprise Value ₹ 2,679 Cr.
ROE % 1.08
RSI Value 36.77
EMA 50 454.26
EMA 200 398.19
Market Cap. ₹ 2,513 Cr.
52 Week - High/Low ₹ 491/112
P/E Ratio
P/B Ratio 2.98
Enterprise Value ₹ 2,523 Cr.
ROE % -0.18
RSI Value 36.77
EMA 50 454.26
EMA 200 398.19

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.